M B Møller

Summary

Affiliation: Odense University Hospital
Country: Denmark

Publications

  1. ncbi request reprint Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma
    M B Møller
    Department of Pathology, Odense University, Denmark
    Clin Cancer Res 5:1085-91. 1999
  2. ncbi request reprint Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features
    M B Møller
    Department of Pathology, Odense University Hospital, Winsløwparken 15, DK 5000 Odense C, Denmark
    Am J Clin Pathol 115:404-12. 2001
  3. ncbi request reprint Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma
    M B Møller
    Department of Pathology, Odense University Hospital, Odense, Denmark
    Histopathology 41:322-30. 2002
  4. ncbi request reprint Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index
    M B Møller
    Department of Pathology, Odense University Hospital, Odense, Denmark
    Br J Haematol 133:43-9. 2006

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma
    M B Møller
    Department of Pathology, Odense University, Denmark
    Clin Cancer Res 5:1085-91. 1999
    ..These results suggest that immunohistochemically assessed p53 status may predict treatment response and outcome in B- and T-cell NHL patients...
  2. ncbi request reprint Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features
    M B Møller
    Department of Pathology, Odense University Hospital, Winsløwparken 15, DK 5000 Odense C, Denmark
    Am J Clin Pathol 115:404-12. 2001
    ..Our results suggest that cyclin D3 is expressed differentially among lymphoma subtypes and that overexpression might identify a subpopulation of patients with indolent lymphoma with adverse clinical features and poor outcome...
  3. ncbi request reprint Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma
    M B Møller
    Department of Pathology, Odense University Hospital, Odense, Denmark
    Histopathology 41:322-30. 2002
    ..The study addresses the currently poorly understood molecular mechanisms underlying relapsing non-Hodgkin's lymphoma...
  4. ncbi request reprint Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index
    M B Møller
    Department of Pathology, Odense University Hospital, Odense, Denmark
    Br J Haematol 133:43-9. 2006
    ..Thus, in the present study, the FLIPI was superior as a prognostic model compared with the IPI and can therefore be recommended as a clinical prognostic index for MCL...